Baxter initiates late-stage study of novel therapy for acute kidney injury

seekingalpha.com
Baxter International

Baxter International commences a Phase 3 clinical trial assessing an investigational drug, Prismocitrate 18, that combines a citrate anticoagulant and renal replacement solution.

Read More